How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)40-44
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume46
Issue number1
Publication statusPublished - Jan 1 2019

Fingerprint

Kidney
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{927ec565e4c34fc18312db1e52abe021,
title = "How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?",
author = "Kenjiro Imada and Masatoshi Eto",
year = "2019",
month = "1",
day = "1",
language = "English",
volume = "46",
pages = "40--44",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?

AU - Imada, Kenjiro

AU - Eto, Masatoshi

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85061569472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061569472&partnerID=8YFLogxK

M3 - Article

C2 - 30765640

AN - SCOPUS:85061569472

VL - 46

SP - 40

EP - 44

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 1

ER -